Ken Griffin’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Buy
627,374
+497,259
+382% +$9.79M ﹤0.01% 2995
2025
Q4
$2.46M Sell
130,115
-196,036
-60% -$3.63M ﹤0.01% 5535
2025
Q3
$6.08M Sell
326,151
-2,794,471
-90% -$52.2M ﹤0.01% 4008
2025
Q2
$57.5M Buy
3,120,622
+2,428,176
+351% +$43.1M 0.01% 1132
2025
Q1
$12.1M Buy
692,446
+161,027
+30% +$2.71M ﹤0.01% 2609
2024
Q4
$9.2M Sell
531,419
-94,479
-15% -$1.73M ﹤0.01% 3091
2024
Q3
$11.6M Sell
625,898
-1,930,852
-76% -$32.6M ﹤0.01% 2682
2024
Q2
$39.4M Buy
2,556,750
+1,320,265
+107% +$18.9M 0.01% 1344
2024
Q1
$18.3M Sell
1,236,485
-1,369,615
-53% -$19M ﹤0.01% 2168
2023
Q4
$37.2M Buy
2,606,100
+1,009,747
+63% +$14.3M 0.01% 1420
2023
Q3
$22.3M Buy
1,596,353
+1,149,926
+258% +$14.7M ﹤0.01% 1750
2023
Q2
$5.25M Sell
446,427
-268,262
-38% -$3.05M ﹤0.01% 3580
2023
Q1
$8.22M Buy
714,689
+229,626
+47% +$2.84M ﹤0.01% 3068
2022
Q4
$6.03M Sell
485,063
-166,589
-26% -$2.12M ﹤0.01% 3561
2022
Q3
$8.55M Sell
651,652
-2,072,087
-76% -$30.6M ﹤0.01% 2997
2022
Q2
$38.1M Buy
2,723,739
+1,462,977
+116% +$19.6M 0.01% 1239
2022
Q1
$18.8M Buy
1,260,762
+321,646
+34% +$4.4M ﹤0.01% 2057
2021
Q4
$12.7M Buy
939,116
+346,121
+58% +$4.9M ﹤0.01% 2670
2021
Q3
$8.73M Buy
592,995
+392,166
+195% +$6.62M ﹤0.01% 3313
2021
Q2
$3.65M Sell
200,829
-36,265
-15% -$646K ﹤0.01% 5145
2021
Q1
$4.12M Buy
237,094
+43,221
+22% +$760K ﹤0.01% 4701
2020
Q4
$3.37M Sell
193,873
-117,460
-38% -$1.87M ﹤0.01% 4381
2020
Q3
$4.29M Sell
311,333
-18,689
-6% -$274K ﹤0.01% 3378
2020
Q2
$4.76M Sell
330,022
-567,679
-63% -$7.46M ﹤0.01% 3155
2020
Q1
$9.8M Sell
897,701
-285,085
-24% -$5.26M ﹤0.01% 1875
2019
Q4
$25.2M Buy
1,182,786
+1,042,459
+743% +$23.3M 0.01% 1281
2019
Q3
$3.22M Sell
140,327
-120,808
-46% -$2.58M ﹤0.01% 3738
2019
Q2
$5.14M Buy
261,135
+125,982
+93% +$2.45M ﹤0.01% 3042
2019
Q1
$2.63M Sell
135,153
-84,427
-38% -$1.6M ﹤0.01% 4007
2018
Q4
$3.62M Buy
219,580
+191,401
+679% +$3.85M ﹤0.01% 3261
2018
Q3
$651K Sell
28,179
-1,361,444
-98% -$30.8M ﹤0.01% 6274
2018
Q2
$30.2M Sell
1,389,623
-866,058
-38% -$16.9M 0.01% 986
2018
Q1
$39.8M Sell
2,255,681
-1,569,324
-41% -$27.7M 0.02% 705
2017
Q4
$71.8M Buy
3,825,005
+2,370,796
+163% +$47.2M 0.04% 456
2017
Q3
$31.9M Buy
1,454,209
+1,244,000
+592% +$28.1M 0.02% 790
2017
Q2
$5.07M Buy
+210,209
New +$5.34M ﹤0.01% 2111
2017
Q1
Sell
-28,740
Closed -$702K 7960
2016
Q4
$702K Buy
28,740
+14,966
+109% +$343K ﹤0.01% 4373
2016
Q3
$347K Sell
13,774
-25,128
-65% -$602K ﹤0.01% 5430
2016
Q2
$803K Sell
38,902
-7,419
-16% -$155K ﹤0.01% 3852
2016
Q1
$931K Buy
+46,321
New +$888K ﹤0.01% 3584
2015
Q4
Sell
-79,292
Closed -$1.84M 9131
2015
Q3
$1.84M Buy
+79,292
New +$2.02M ﹤0.01% 3052
2015
Q1
Sell
-74,824
Closed -$2.27M 8808
2014
Q4
$2.27M Buy
74,824
+63,055
+536% +$1.74M ﹤0.01% 2760
2014
Q3
$286K Buy
+11,769
New +$326K ﹤0.01% 5318
2014
Q2
Sell
-73,613
Closed -$2.05M 8265
2014
Q1
$2.05M Buy
73,613
+19,129
+35% +$525K ﹤0.01% 2629
2013
Q4
$1.42M Buy
+54,484
New +$1.4M ﹤0.01% 2864

Other funds holding SBRA

Ken Griffin's SBRA Position: Q1 2026 in Review

Ken Griffin increased its Sabra Healthcare REIT (SBRA) stake by 382% in Q1 2026, buying an estimated $9.79M and bringing the position to 627,374 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Ken Griffin first reported a position in SBRA in Q4 2013 and has held it in 45 quarters since. The position peaked at $71.8M in Q4 2017. 460 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Ken Griffin held 627,374 shares of Sabra Healthcare REIT worth $12.1M as of Q1 2026.
  • Ken Griffin bought 497,259 Sabra Healthcare REIT shares in Q1 2026, an estimated $9.79M.
  • Sabra Healthcare REIT made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #2995 holding.
  • Ken Griffin first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 45 quarters since.
  • Ken Griffin's Sabra Healthcare REIT position peaked at $71.8M in Q4 2017.
  • 460 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.